7 research outputs found
Polymerisation and export of alginate in Pseudomanas aeruginosa : functional assignment and catalytic mechanism of Alg8/44 : a thesis presented to Massey University in partial fulfilment of the requirement for the degree of Doctor of Philosophy in Microbiology
Alginate biosynthesis is not only a major contributor to pathogenicity of P. aeruginosa but also an
important factor in colonization of adverse environmental habitats by biofilm formation. The
requirement of proteins Alg8 and Alg44, encoded by their respective genes in the alginate
biosynthesis gene cluster, for alginate biosynthesis of P. aeruginosa was demonstrated, since
deletion mutants were unable to produce or polymerise alginate. AlgX deletion mutants failed to
produce the alginate characteristic mucoid phenotype, but showed low concentrations of uronic
acid monomers in the culture supernatants. Complementation experiments using PCR based
approaches were used to determine the complementing ORF and all deletion mutants could be
complemented to at least wildtype levels by introducing a plasmid harbouring the respective gene.
Increased copy numbers of Alg44 did not impact on the amount of alginate produced, whereas
increased copy numbers of the alg8 gene led to an at least 10 fold stronger alginate production
impacting on biofilm structure and stability. Topological analysis using reporter protein fusions
and subsequent subcellular fractionation experiments revealed that Alg8 is located in the
cytoplasmic membrane and contains at least 4 transmembrane helices, 3 of them at its C
terminus. Its large cytosolic loop showed similarities to inverting glycosyltransferases and the
similarities were used to generate a threading model using SpsA, a glycosyltransferase involved in
spore coat formation of B. subtilis, as a template. Site-directed mutagenesis confirmed the
importance of identified motifs commonly detected in glycosyltransferases. Inactivation of the
DXD motif, which has been shown to be involved in nucleotide sugar binding, led to loss-offunction
mutants of Alg8 and further replacements revealed putative candidates for the catalytic
residue(s). Contradicting the commonly reported prediction of being a transmembrane protein,
Alg44 was shown to be a periplasmic protein. The highest specific alkaline phosphatase activity
of its fusion protein could be detected in the periplasmic fraction and not in the insoluble
membrane fraction. Bioinformatical analysis of Alg44 revealed structural similarities of its N
terminus to PilZ domains, shown to bind cyclic-di-GMP, and of its C terminus to MexA, a
membrane fusion protein involved in multi-drug efflux systems. Thus, it was suggested that
Alg44 has a regulatory role for alginate biosynthesis in bridging the periplasm and connecting
outer and cytoplasmic membrane components. AlgX was shown to interact with MucD, a
periplasmic serine protease or chaperone homologue, and is suggested to exert its impact on
alginate production via MucD interaction. In vitro alginate polymerisation assays revealed that
alginate production requires protein components of the outer and cytoplasmic membrane as well
as the periplasm, and these data were used to construct a model describing a multi-enzyme,
membrane and periplasm spanning complex for alginate polymerisation, modification and export
Alg44, a unique protein required for alginate biosynthesis in Pseudomonas aeruginosa
AbstractHere the putative alginate biosynthesis gene alg44 of Pseudomonas aeruginosa was functionally assigned. Non-polar isogenic alg44 deletion mutants of P. aeruginosa were generated and did neither produce alginate nor released free uronic acids. No evidence for alginate enrichment in the periplasm was obtained. Alginate production was restored by introducing only the gene alg44. PhoA fusion protein analyses suggested that Alg44 is a soluble protein localized in the periplasm. Hexahistidine-tagged Alg44 was detected by immunoblotting. The corresponding 42.6kDa protein was purified and identified by MALDI/TOF-MS analysis. Alg44 might be directly involved in alginate polymerization presumably by exerting a regulatory function
Quantitative determination of cyclic diguanosine monophosphate concentrations in nucleotide extracts of bacteria by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry.
The physiological response to small molecules (secondary messengers) is the outcome of a delicate equilibrium between biosynthesis and degradation of the signal. Cyclic diguanosine monophosphate (c-di-GMP) is a novel secondary messenger present in many bacteria. It has a complex cellular metabolism whereby usually more than one enzyme synthesizing and degrading c-di-GMP is encoded by a bacterial genome. To assess the in vivo conditions of c-di-GMP signaling, we developed a high-performance liquid chromatography (HPLC)-mass spectrometry-based method to detect c-di-GMP with high sensitivity and to quantify the c-di-GMP concentration in the bacterial cell as described here in detail. We successfully used the methodology to determine and compare the c-di-GMP concentrations in bacterial species such as Salmonella typhimurium, Escherichia coli, Pseudomonas aeruginosa, and Vibrio cholerae. We describe the use of the methodology to assess the change in c-di-GMP concentration during the growth phase and the contribution of a point mutation in S. typhimurium to the overall cellular c-di-GMP concentration
A Role for the EAL-Like Protein STM1344 in Regulation of CsgD Expression and Motility in Salmonella enterica Serovar Typhimuriumâ–ż
The bacterial second messenger cyclic di-GMP (c-di-GMP) regulates the transition between sessility and motility. In Salmonella enterica serovar Typhimurium, the expression of CsgD, the regulator of multicellular rdar morphotype behavior, is a major target of c-di-GMP signaling. CsgD expression is positively regulated by at least two diguanylate cyclases, GGDEF domain proteins, and negatively regulated by at least four phosphodiesterases, EAL domain proteins. Here, we show that in contrast to EAL domain proteins acting as phosphodiesterases, the EAL-like protein STM1344 regulated CsgD expression positively and motility negatively. STM1344, however, did not have a role in c-di-GMP turnover and also did not bind the nucleotide. STM1344 acted upstream of the phosphodiesterases STM1703 and STM3611, previously identified to participate in CsgD downregulation, where it repressed their expression. Consequently, although STM1344 has not retained a direct role in c-di-GMP metabolism, it still participates in the regulation of c-di-GMP turnover and has a role in the transition between sessility and motility